Families living in remote areas face unique challenges for bleeding disorders care. Learn how a few families have managed—and how local providers can help.
More than 40% of Americans have delayed or avoided medical care during the COVID-19 pandemic, according to the Centers for Disease Control and Prevention. But if you have a bleeding disorder, healthcare delays can have serious consequences.
Update, August 2013: The FDA approved Tivicay® (dolutegravir), manufactured by ViiV Healthcare, a GlaxoSmithKline company. Tivicay is an integrase strand...
Accomplished pediatric researcher advances study of pediatric bleeding disorders.HemAware is conducting a series of interviews with recipients of the NHF-Baxter...